CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 69 enrolled
Drug / intervention
Alcohol vs. Placeboother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03567434
NCT03567434N/ACompleted

Randomized, Double-Blind, Placebo-Based Study to Determine Effect of Evening Alcohol on Sympathetic Neural Activity and Baroreflex Function in Binge Drinkers

Baylor University·interventional·Posted Jun 25, 2018·Updated Sep 24, 2024

In Brief

A clinical study evaluating Alcohol vs. Placebo for Binge Drinking. Completed, enrolled 69 participants across 1 site.

Detailed Summary

This study evaluates the impact of evening alcohol consumption on sympathetic activity and baroreflex function in binge drinkers. Our central hypothesis is that evening binge alcohol consumption will lead to sympathetic overactivity and blunted baroreflex function.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBinge Drinking
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 25, 2018
Enrollment StartMay 21, 2018
Primary CompletionJul 1, 2022
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 8.0 years ago

Interventions

Alcohol vs. Placeboother

Using a randomized, cross-over design, all subjects will consume evening alcohol (and a fluid-control placebo) in a dose that mimics binge drinking.